Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > AGM

<< Previous

Bullboard Posts

Next >>

Comment by StockingUp21on Aug 05, 2022 1:29pm

103 Views

Post# 34874677

RE:RE:RE:AGM

Speak of brains loosing all your money to a pilot who runs a science company lmao!

Inthepez wrote:

oh snap. Chichi is back lmao! Please make sure everyone go through his comments. Note his affinity to mugsy and his similarities to stutters for brains.

He must've taken a page from dumpster and Czechcashings lol!

Chianchin wrote: Mad Monk, ATE is a lottery ticket with better odds. $.70 to loose $4 to win